“Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy”. Farmeconomia. Health economics and therapeutic pathways 22, no. 1 (June 18, 2021). Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1499.